A pathologist’s view on the testis biopsy
- 26 July 2011
- journal article
- review article
- Published by Wiley in International Journal of Andrology
- Vol. 34 (4pt2) , e14
Abstract
Summary: Aspects of the biopsy of the testis from the pathologist’s point of view are discussed. Direct enzyme‐histochemical staining for alkaline phosphatase (dAP) on frozen sections of biopsies taken during operation is a useful diagnostic tool to aid surgeons in testis‐sparing surgery. Biopsy of the contralateral testis for the diagnosis of carcinoma in situ (CIS) in patients with a testicular germ cell tumour is not standard of care in most countries because of the high rate of negative biopsies. Based on risk factors for germ cell tumours, i.p. microlithiasis, a patient population is defined in which the rate of CIS in the contralateral biopsy is about 25%. It is reiterated that the diagnosis of CIS in testicular biopsies requires expertise, and should not be carried out without immunohistochemistry for markers for CIS. As OCT3/4 is increasingly used as marker, it is important to be aware that it may be false‐negative in biopsies fixed in Bouin’s or Stieve’s fixative. Preliminary results are presented on a series of biopsies from cryptorchid testes in infants and children allowing the definition of morphological and immunohistochemical criteria for delayed maturation of gonocytes and pre‐CIS.Keywords
This publication has 30 references indexed in Scilit:
- Testicular microlithiasis and carcinomain situoverview and proposed clinical guidelineInternational Journal of Andrology, 2009
- A genome-wide association study of testicular germ cell tumorNature Genetics, 2009
- Common variation in KITLG and at 5q31.3 predisposes to testicular germ cell cancerNature Genetics, 2009
- European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): Part IIEuropean Urology, 2008
- Testicular dysgenesis syndrome and the origin of carcinoma in situ testisInternational Journal of Andrology, 2008
- Testicular germ-cell tumours in a broader perspectiveNature Reviews Cancer, 2005
- Transcription Factor AP-2γ Is a Developmentally Regulated Marker of Testicular CarcinomaIn situand Germ Cell TumorsClinical Cancer Research, 2004
- A new approach using tissue alkaline phosphatase activity to identify early testicular cancerBritish Journal of Urology, 1997
- Morphology of normal and malignant germ cells*International Journal of Andrology, 1987
- POSSIBLE CARCINOMA-IN-SITU OF THE TESTISThe Lancet, 1972